These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11740722)

  • 1. Antifungal prophylaxis and the rate of bacteremia among neutropenic patients.
    Viscoli C; Paesmans M;
    Clin Infect Dis; 2002 Jan; 34(2):289-91. PubMed ID: 11740722
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on: Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
    Cornely OA; Ullmann AJ; Karthaus M
    J Antimicrob Chemother; 2006 Jan; 57(1):151-2; author reply 152-4. PubMed ID: 16314347
    [No Abstract]   [Full Text] [Related]  

  • 3. Antimicrobial prophylaxis for infection in neutropenic patients.
    Bodey GP
    Curr Clin Top Infect Dis; 1988; 9():1-43. PubMed ID: 3077285
    [No Abstract]   [Full Text] [Related]  

  • 4. Association between antifungal prophylaxis and rate of documented bacteremia in febrile neutropenic cancer patients.
    Viscoli C; Paesmans M; Sanz M; Castagnola E; Klastersky J; Martino P; Glauser M;
    Clin Infect Dis; 2001 Jun; 32(11):1532-7. PubMed ID: 11340522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prophylaxis of infection in neutropenic patients. Guidelines of the Working Party on Infections in Hematology and Oncology].
    Kern WV; Beyer J; Böhme A; Buchheidt D; Cornely O; Einsele H; Kisro J; Krüger W; Maschmeyer G; Ruhnke M; Schmidt CA; Schwartz S; Szelenyi H;
    Dtsch Med Wochenschr; 2000 Dec; 125(51-52):1582-8. PubMed ID: 11199452
    [No Abstract]   [Full Text] [Related]  

  • 6. Comment to the article of C. C. Kibbler: antifungal prophylaxis with itraconazole oral solution in neutropenic patients.
    Silling G
    Mycoses; 1999; 42 Suppl 2():124. PubMed ID: 10865919
    [No Abstract]   [Full Text] [Related]  

  • 7. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?
    Klastersky J
    J Antimicrob Chemother; 2009 May; 63 Suppl 1():i14-5. PubMed ID: 19372173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials.
    Bow EJ; Laverdière M; Lussier N; Rotstein C; Cheang MS; Ioannou S
    Cancer; 2002 Jun; 94(12):3230-46. PubMed ID: 12115356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients.
    Glasmacher A; Prentice A; Gorschlüter M; Engelhart S; Hahn C; Djulbegovic B; Schmidt-Wolf IG
    J Clin Oncol; 2003 Dec; 21(24):4615-26. PubMed ID: 14673051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infections in neutropenic patients I: aetiology.
    Engervall P; Björkholm M
    Med Oncol; 1995 Dec; 12(4):251-6. PubMed ID: 8832528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and therapy of infections in neutropenic patients].
    Hiddemann W
    Krankenpfl J; 1993 Apr; 31(4):146-50. PubMed ID: 8231078
    [No Abstract]   [Full Text] [Related]  

  • 12. Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study.
    Riedel A; Choe L; Inciardi J; Yuen C; Martin T; Guglielmo BJ
    BMC Infect Dis; 2007 Jul; 7():70. PubMed ID: 17605773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preemptive antifungal therapy among neutropenic patients.
    Stefani PM; Gottardi M; Zanetti F; Tecchio C; Sartor D; Gherlinzoni F
    Clin Infect Dis; 2006 May; 42(10):1507-8; author reply 1508-9. PubMed ID: 16619177
    [No Abstract]   [Full Text] [Related]  

  • 14. Antifungal prophylaxis and empiric therapy in neutropenic patients.
    Cauwenbergh G
    Arch Med Res; 1993; 24(4):417-25. PubMed ID: 8118167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The prevention and treatment of fungal infections in the neutropenic patient].
    Vázquez López ML
    Rev Clin Esp; 1997 Apr; 197 Suppl 1():29-34. PubMed ID: 9297203
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mycotic infections in neutropenic patients. Necessary with adequate prevention].
    Björkholm M; Engervall P; Grimfors G
    Lakartidningen; 1994 Nov; 91(48):4492-4. PubMed ID: 7808159
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prevention of mycotic infections in oncology patients with regard to the toxicity of antimycotic agents].
    Doubek M; Mayer J; Horký D; Doubek J; Rácil Z; Vorlícek J
    Vnitr Lek; 2002 Mar; 48(3):248-54. PubMed ID: 11968587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
    Glasmacher A; Prentice AG
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i23-i32. PubMed ID: 16120631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antimicrobial prophylaxis and therapy in neutropenia].
    Link H
    Mycoses; 2003; 46 Suppl 2():21-32. PubMed ID: 15055140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial prophylaxis in febrile neutropenia.
    Yoshida M; Ohno R
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S65-7. PubMed ID: 15250025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.